Liquid Biopsy Market (Covid-19) Impact and Analysis by 2027 | Biocept, inc., Bio-Rad Laboratories, Lunglifeai, Exosome Diagnostics, F. Hoffmann-la Roche, Inivata ltd,Exact sciences corporation, Mdxhealth, Qiagen, and Thermo fisher scientific

The Insight Partners analysts forecasts the latest report on “Liquid Biopsy Market (Covid-19) Impact and Analysis by 2027”, according to report; The Liquid Biopsy Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Liquid Biopsy Market.

The study provides details such as the market share, Market Insights, Strategic Insights, Segmentation and key players in the Liquid Biopsy Market.

Download Sample Report of Liquid Biopsy Market Report @ https://www.theinsightpartners.com/sample/TIPRE00003996/?openpr-10225

(*If you have any special requirements, please let us know and we will offer you the report as you want.)
The liquid biopsy market was valued at US$ 3,861.49 million in 2019and is projected to reach US$ 8,123.85 million by 2027; it is expected to grow at a CAGR of 9.9% during 2020–2027.

Some of the Major Market Players Are:
Biocept, Inc
Bio-Rad Laboratories Inc
LungLife AI, Inc
Exosome Diagnostics
F. Hoffmann-la Roche ltd
Exact Sciences Corporation
Inivata Ltd
MDxHealth
Qiagen
Thermo Fisher Scientific Inc.

Market Insights

Government and Global Health Organizations Initiatives

The liquid biopsy test is conducted to detect cancer at an early stage. The test is performed either on a blood sample to identify cancer cells present in the in blood stream, or on the DNA extracted from tumor cells. The government for early detection of cancer takes various initiatives. For instance, the National Institutes of Health (NIH) started a new initiative called Precompetitive Collaboration on liquid biopsy for early cancer assessment. The purposes of this initiative are to establish a Public-Private Partnership Program for the development of new or validate existing technologies, methods, and assays for the capture and quantification of tumor-associated cells, RNA, DNA, or exosomes in body fluids of patients with an early-stage disease or those at high risk. This initiative emphasis early cancer detection by distinguishing aggressive and nonaggressive cancers, and differentiates benign disease from cancer.

The NCI'scommitment of funds towards R&D of clinical advanced technology will encourage the investigators to expand their research for early detection of cancer and accelerate clinical adoption of these promising technologies.

In China and the US, the central government and biotech investors have been financing lung cancer screening by investing in Research & Development and complementary or improved screening tools and diagnostics, such as biomarkers and liquid biopsies.

Product and Services Insights

Based on product and services the liquid biopsy market is segmented into equipment, reagents & kits and services. The reagents & kits segment held the largest share of the market in 2019 and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Sample Insights

Based on sample, the liquid biopsy market is segmented into blood based, urine based, and other samples. The blood basedsegment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period owing to its remarkable advantages over the conventional method.

Circulating Biomarker Insights

Based on circulating biomarker, the liquid biopsy market is segmented into circulating tumor cells (CTC), exosomes, and free nucleic acid. The circulating tumor cells (CTC) segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period. Factors helping to remain CTC market dominate are advantages over traditional tissue biopsies, as they are non-invasive, can be used repeatedly, and provide more useful information on cancerous cell risk, disease progression, and treatment

Applications Insights

Based on application, the liquid biopsy market has been segmented into noninvasive prenatal testing (NIPT), oncology, transplant diagnostics, and other applications. The oncology segment held the largest share of the market in 2019; however, noninvasive prenatal testing (NIPT) segment is estimated to register the highest CAGR in the market during the forecast period.

End-User Insights

Based on end user, the liquid biopsy market has been segmented into academic & research institutes, hospitals, reference laboratories, and other end users. The hospitals segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Product launches and approval strategies are commonly adopted by companies to expand their footprint worldwide and meet the growing demand.

The market players operating in the liquid biopsy market adopt the business expansion to enlarge customer base across the world, collaborations, and product launches. These strategies permit the players to maintain their brand name globally. For instance, in August 2018, Exact Sciences Corp. announced signing of partnership with Pfizer to promote Colorguard in the US. Pfizer has helped with sales representative to promote the test to physicians and health systems during marketing campaign.

Liquid Biopsy Market - By Product & Service

• Equipment
• Reagents & Kits
• Services

Liquid Biopsy Market - By Sample

• Blood Based
• Urine Based
• Other samples

Liquid Biopsy Market - By Circulating Biomarker

• Circulating Tumor Cells (CTC)
• Exosomes
• Free Nucleic Acid

Liquid Biopsy Market - By Application

• Noninvasive Prenatal Testing (NIPT)
• Oncology
• Transplant Diagnostics
• Other Applications

Liquid Biopsy Market - By End User

• Academic & Research Institutes
• Hospitals
• Reference Laboratories
• Other End Users

The report analyses factors affecting the Liquid Biopsy Market from further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Liquid Biopsy Market in these regions.
Moreover, the report entails the estimate and analysis for the Liquid Biopsy Market on a global as well as regional level. The study provides historical data as well as the trending features and future predictions of the market growth. Further, the report encompasses drivers and restraints for the Liquid Biopsy Market growth along with its impact on the overall market development. In addition, the report provides an analysis of the accessible avenues in the market on a global level.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global Liquid Biopsy Market based on various segments. It also provides market size and forecast estimates from the year 2018 to 2027 with respect to five major regions. The Liquid Biopsy Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Promising Regions & Countries Mentioned in The Liquid Biopsy Market Report:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East & Africa

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Major Features of Liquid Biopsy Market Report:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Liquid Biopsy market
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global Liquid Biopsy market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.

Purchase a copy of Liquid Biopsy Market research report @ https://www.theinsightpartners.com/buy/TIPRE00003996/?openpr-10225

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.